13/10/2026
Welcome back to Trial Talk Tuesday!
In this two-part series, we are breaking down what the next steps look like for both participants and the drug.
First up: the patient journey.
Immediately after participant visits end, researchers enter a critical data analysis period to assemble and interpret the study results.
Every participant receives an exit overview to discuss their experience, ask questions, and learn about potential next steps, including when study results will be shared.
For some patients, this means transitioning back to standard care under their primary physician. For others, particularly if the treatment proved successful, they may continue receiving it through an open-label extension study or an expanded access program while waiting for formal approval.
Once all participant data has been analysed, final trial results are shared back with participants and published for the medical community.
Your participation plays a crucial role in bringing new healthcare solutions to life.
Interested in joining a medical study? Explore active trials today at clinrol.com/patients